Predictors of trimodality therapy and trends in therapy for malignant pleural mesothelioma†

Long-Term Survival Outcomes of Cancer-Directed Surgery for Malignant Pleural Mesothelioma: Propensity Score Matching Analysis

(2017) David B. Nelson et al.   JOURNAL OF CLINICAL ONCOLOGY

OA13.01 A Phase II Study of Nivolumab in Malignant Pleural Mesothelioma (NivoMes): with Translational Research (TR) Biopies

(2017) Josine Quispel-Janssen et al.   Journal of Thoracic Oncology

Determinants of Survival in Malignant Pleural Mesothelioma: A Surveillance, Epidemiology, and End Results (SEER) Study of 14,228 Patients

(2015) Emanuela Taioli et al.   PLoS One

Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation in the treatment of pleural mesothelioma

(2013) Rea Federico et al.   BMC CANCER

The role of surgical cytoreduction in the treatment of malignant pleural mesothelioma: Meeting summary of the International Mesothelioma Interest Group Congress, September 11-14, 2012, Boston, Mass

(2013) Valerie Rusch et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study

(2011) Tom Treasure et al.   LANCET ONCOLOGY

Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial

(2010) P. E. Van Schil et al.   EUROPEAN RESPIRATORY JOURNAL

Frequency of Use and Predictors of Cancer-Directed Surgery in the Management of Malignant Pleural Mesothelioma in a Community-Based (Surveillance, Epidemiology, and End Results [SEER]) Population

(2010) Raja M. Flores et al.   Journal of Thoracic Oncology

Multicenter Phase II Trial of Neoadjuvant Pemetrexed Plus Cisplatin Followed by Extrapleural Pneumonectomy and Radiation for Malignant Pleural Mesothelioma

(2009) Lee M. Krug et al.   JOURNAL OF CLINICAL ONCOLOGY